RecruitingNCT04261829

AFT: Introduction of a Full Breast Reconstructive Method

Autologous Fat Transfer: Introduction of a Full Breast Reconstructive Method


Sponsor

Maastricht University Medical Center

Enrollment

350 participants

Start Date

Dec 9, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

A multicentre prospective cohort study will monitor the efficacy and safety of Autologous Fat Transfer (AFT) with pre-expansion. AFT will be evaluated in terms of quality of life, aesthetic result, complications, oncological safety and cost-effectiveness. It follows the BREAST trial, the randomised controlled trial comparing AFT with implant-based reconstruction. In this study, patients all receive AFT.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria7

  • Female gender
  • Age of 18 years and older
  • History or in candidate for a mastectomy procedure in the near future
  • Patients undergoing preventive mastectomy
  • Patients' choice to undergo a breast reconstruction
  • Wanting to participate in this study
  • Patient is able to wear the external expansion device

Exclusion Criteria15

  • Active smoker or a history of smoking 4 weeks prior to surgery
  • Current substance abuse
  • History of lidocaine allergy
  • History of silicone allergy
  • weeks or less after chemotherapy
  • History of radiation therapy in the breast region
  • Oncological treatment includes radiotherapy after mastectomy
  • Kidney disease
  • Steroid dependent asthma (daily or weekly) or other diseases
  • Immune-suppressed or compromised disease
  • Uncontrolled diabetes
  • BMI\>30
  • Large breast size (i.e. larger than cup C), unless the patient prefers reduction of the contralateral side towards Cup C
  • Extra-capsular silicone leaking from the encapsulated implant from a previous breast reconstruction
  • The treating plastic surgeon has strong doubts on the patient's treatment compliance

Interventions

PROCEDUREAutologous Fat Transfer

Female breast cancer patients who were surgically treated with mastectomy could opt for a full breast reconstruction with Autologous Fat Transfer in combination with external expansion.


Locations(8)

Maastricht University Medical Center+

Maastricht, Limburg, Netherlands

Viecuri Venlo

Venlo, Limburg, Netherlands

Amsterdam University Medical Center (VUMC)

Amsterdam, Netherlands

Rijnstate

Arnhem, Netherlands

Alexander Monro, Bilthoven

Bilthoven, Netherlands

Amphia

Breda, Netherlands

Ziekenhuis groep Twente (ZGT)

Hengelo, Netherlands

Medical Center Leeuwarden

Leeuwarden, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04261829


Related Trials